These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of Herpes Simplex Virus Infectious Epithelial Keratitis During Oral Acyclovir Therapy and Response to Topical Antivirals. Carter SB; Cohen EJ Cornea; 2016 May; 35(5):692-5. PubMed ID: 26989961 [TBL] [Abstract][Full Text] [Related]
3. Management of herpes simplex virus epithelial keratitis. Roozbahani M; Hammersmith KM Curr Opin Ophthalmol; 2018 Jul; 29(4):360-364. PubMed ID: 29697435 [TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Tsatsos M; MacGregor C; Athanasiadis I; Moschos MM; Hossain P; Anderson D Clin Exp Ophthalmol; 2016 Dec; 44(9):824-837. PubMed ID: 27273328 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group. Wilhelmus KR; Dawson CR; Barron BA; Bacchetti P; Gee L; Jones DB; Kaufman HE; Sugar J; Hyndiuk RA; Laibson PR; Stulting RD; Asbell PA Br J Ophthalmol; 1996 Nov; 80(11):969-72. PubMed ID: 8976723 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of four antiviral agents in the treatment of uncomplicated herpetic keratitis. Panda A; Das GK; Khokhar S; Rao V Can J Ophthalmol; 1995 Aug; 30(5):256-8. PubMed ID: 8529160 [TBL] [Abstract][Full Text] [Related]
7. The treatment of herpes simplex virus epithelial keratitis. Wilhelmus KR Trans Am Ophthalmol Soc; 2000; 98():505-32. PubMed ID: 11190039 [TBL] [Abstract][Full Text] [Related]
8. [Herpetic keratitis. Clinical and therapeutic aspects]. Pop R; Macarie S; Malachi A Oftalmologia; 1997; 41(2):56-9. PubMed ID: 15328644 [TBL] [Abstract][Full Text] [Related]
9. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Wilhelmus KR Cochrane Database Syst Rev; 2010 Dec; (12):CD002898. PubMed ID: 21154352 [TBL] [Abstract][Full Text] [Related]
10. The impact of the herpetic eye disease studies on the management of herpes simplex virus ocular infections. Sudesh S; Laibson PR Curr Opin Ophthalmol; 1999 Aug; 10(4):230-3. PubMed ID: 10621528 [TBL] [Abstract][Full Text] [Related]
11. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Barron BA; Gee L; Hauck WW; Kurinij N; Dawson CR; Jones DB; Wilhelmus KR; Kaufman HE; Sugar J; Hyndiuk RA Ophthalmology; 1994 Dec; 101(12):1871-82. PubMed ID: 7997323 [TBL] [Abstract][Full Text] [Related]
12. Reactivation of Herpes Simplex Keratitis on a Corneal Graft Following SARS-CoV-2 mRNA Vaccination. Al-Dwairi RA; Aleshawi A; Adi S; Abu-Zreig L Med Arch; 2022 Apr; 76(2):146-148. PubMed ID: 35774041 [TBL] [Abstract][Full Text] [Related]
13. Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis. Wu X; Chen X Chin Med J (Engl); 2002 Oct; 115(10):1569-72. PubMed ID: 12490113 [TBL] [Abstract][Full Text] [Related]